氯e6衍生物介导的光动力疗法与强力霉素治疗中重度酒渣鼻:一项前瞻性、随机、对照研究。

IF 3.1 3区 医学 Q2 ONCOLOGY
Yun Wu , Qing Fan , Xiaojing Liu , Yajing Cao , Jin Yang , Yu Yan , Hui Tao , Fuhe Zhang , Linglin Zhang , Peiru Wang , Xiuli Wang
{"title":"氯e6衍生物介导的光动力疗法与强力霉素治疗中重度酒渣鼻:一项前瞻性、随机、对照研究。","authors":"Yun Wu ,&nbsp;Qing Fan ,&nbsp;Xiaojing Liu ,&nbsp;Yajing Cao ,&nbsp;Jin Yang ,&nbsp;Yu Yan ,&nbsp;Hui Tao ,&nbsp;Fuhe Zhang ,&nbsp;Linglin Zhang ,&nbsp;Peiru Wang ,&nbsp;Xiuli Wang","doi":"10.1016/j.pdpdt.2025.104474","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Photodynamic therapy (PDT) is beneficial for managing rosacea, and chlorin e6 derivative-mediated photodynamic therapy (STBF-PDT) has demonstrated efficacy in reducing acne lesions with mild adverse reactions.</div></div><div><h3>Objectives</h3><div>This study aimed to assess the effectiveness and safety of STBF-PDT for the treatment of moderate-to-severe rosacea.</div></div><div><h3>Methods</h3><div>In this prospective, randomised, evaluator-blind controlled study, patients with moderate-to-severe rosacea were assigned to receive up to six STBF-PDT sessions or 100 mg of doxycycline daily for eight weeks, followed by a 24-week follow-up.</div></div><div><h3>Results</h3><div>A total of 76 patients were enrolled (38 assigned to STBF-PDT and 38 to oral doxycycline) with 69 (36 in the STBF-PDT group and 33 in the doxycycline group) completing the study. At the end of treatment, the median reduction in lesion count was 82.3 % in the STBF-PDT group and 81.8 % in the doxycycline group, indicating no significant difference between the groups. The STBF-PDT group exhibited a lower relapse rate and a significantly higher reduction in <em>Demodex</em> mites. Clinician's Erythema Assessment success (CEA), sensations of burning and pruritus, telangiectasia, and Rosacea-related Quality of Life (RosaQoL) scores were comparable between groups. No severe adverse reactions were observed.</div></div><div><h3>Conclusions</h3><div>STBF-PDT is a promising treatment option for mild-to-moderate rosacea with mild adverse reactions.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"51 ","pages":"Article 104474"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study\",\"authors\":\"Yun Wu ,&nbsp;Qing Fan ,&nbsp;Xiaojing Liu ,&nbsp;Yajing Cao ,&nbsp;Jin Yang ,&nbsp;Yu Yan ,&nbsp;Hui Tao ,&nbsp;Fuhe Zhang ,&nbsp;Linglin Zhang ,&nbsp;Peiru Wang ,&nbsp;Xiuli Wang\",\"doi\":\"10.1016/j.pdpdt.2025.104474\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Photodynamic therapy (PDT) is beneficial for managing rosacea, and chlorin e6 derivative-mediated photodynamic therapy (STBF-PDT) has demonstrated efficacy in reducing acne lesions with mild adverse reactions.</div></div><div><h3>Objectives</h3><div>This study aimed to assess the effectiveness and safety of STBF-PDT for the treatment of moderate-to-severe rosacea.</div></div><div><h3>Methods</h3><div>In this prospective, randomised, evaluator-blind controlled study, patients with moderate-to-severe rosacea were assigned to receive up to six STBF-PDT sessions or 100 mg of doxycycline daily for eight weeks, followed by a 24-week follow-up.</div></div><div><h3>Results</h3><div>A total of 76 patients were enrolled (38 assigned to STBF-PDT and 38 to oral doxycycline) with 69 (36 in the STBF-PDT group and 33 in the doxycycline group) completing the study. At the end of treatment, the median reduction in lesion count was 82.3 % in the STBF-PDT group and 81.8 % in the doxycycline group, indicating no significant difference between the groups. The STBF-PDT group exhibited a lower relapse rate and a significantly higher reduction in <em>Demodex</em> mites. Clinician's Erythema Assessment success (CEA), sensations of burning and pruritus, telangiectasia, and Rosacea-related Quality of Life (RosaQoL) scores were comparable between groups. No severe adverse reactions were observed.</div></div><div><h3>Conclusions</h3><div>STBF-PDT is a promising treatment option for mild-to-moderate rosacea with mild adverse reactions.</div></div>\",\"PeriodicalId\":20141,\"journal\":{\"name\":\"Photodiagnosis and Photodynamic Therapy\",\"volume\":\"51 \",\"pages\":\"Article 104474\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Photodiagnosis and Photodynamic Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1572100025000043\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photodiagnosis and Photodynamic Therapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1572100025000043","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:光动力疗法(PDT)有利于治疗酒渣鼻,氯e6衍生物介导的光动力疗法(STBF-PDT)已被证明可以减少痤疮病变,且不良反应轻微。目的:本研究旨在评估STBF-PDT治疗中重度酒渣鼻的有效性和安全性。​结果:共有76例患者入组(38例分配到STBF-PDT组,38例分配到口服强力霉素组),其中69例(STBF-PDT组36例,强力霉素组33例)完成了研究。治疗结束时,STBF-PDT组和强力霉素组的中位病变计数减少率分别为82.3%和81.8%,两组间无显著差异。STBF-PDT组表现出较低的复发率和显著较高的蠕形螨的减少。临床医生的红斑评估成功(CEA)、灼烧和瘙痒的感觉、毛细血管扩张和红斑痤疮相关的生活质量(RosaQoL)评分在两组之间具有可比性。未见严重不良反应。结论:STBF-PDT治疗轻至中度酒渣鼻是一种有希望的治疗选择,不良反应轻微。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study

Background

Photodynamic therapy (PDT) is beneficial for managing rosacea, and chlorin e6 derivative-mediated photodynamic therapy (STBF-PDT) has demonstrated efficacy in reducing acne lesions with mild adverse reactions.

Objectives

This study aimed to assess the effectiveness and safety of STBF-PDT for the treatment of moderate-to-severe rosacea.

Methods

In this prospective, randomised, evaluator-blind controlled study, patients with moderate-to-severe rosacea were assigned to receive up to six STBF-PDT sessions or 100 mg of doxycycline daily for eight weeks, followed by a 24-week follow-up.

Results

A total of 76 patients were enrolled (38 assigned to STBF-PDT and 38 to oral doxycycline) with 69 (36 in the STBF-PDT group and 33 in the doxycycline group) completing the study. At the end of treatment, the median reduction in lesion count was 82.3 % in the STBF-PDT group and 81.8 % in the doxycycline group, indicating no significant difference between the groups. The STBF-PDT group exhibited a lower relapse rate and a significantly higher reduction in Demodex mites. Clinician's Erythema Assessment success (CEA), sensations of burning and pruritus, telangiectasia, and Rosacea-related Quality of Life (RosaQoL) scores were comparable between groups. No severe adverse reactions were observed.

Conclusions

STBF-PDT is a promising treatment option for mild-to-moderate rosacea with mild adverse reactions.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.80
自引率
24.20%
发文量
509
审稿时长
50 days
期刊介绍: Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信